Highly scalable prefusion-stabilized RSV F vaccine with enhanced immunogenicity and robust protection

Journal:

Nature Communications

Published:

2025-08-21

DOI:

10.1038/s41467-025-63084-z

Affiliations:

5

Authors:

16

Go to article

Institutions	Authors	Share
Changping Laboratory, China	10.000000 10.000000	0.63
Capital Institute of Pediatrics, China	3.000000	0.19
Institute of Microbiology (IM), CAS, China	1.500000	0.09
University of Chinese Academy of Sciences (UCAS), China	1.000000	0.06
Beijing Normal University (BNU), China	0.500000	0.03

Interested in Biochemistry and Cell Biology?